AI assistant
BIO-TECHNE Corp — Director's Dealing 2016
Jul 6, 2016
30718_dirs_2016-07-06_ed56142a-7136-4c36-b054-88fca42e6d0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-07-01
Reporting Person: Eansor Norman David (SVP - Novus Biologicals)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-01 | Common Stock | F | 533 | $112.24 | Disposed | 3936 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (15000) | 15000 | Direct |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (9375) | 9375 | Direct |
| Restricted Stock Units | $ | Common Stock (1500) | 1500 | Direct |
Footnotes
F1: The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit grant by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
F2: Includes 1,666 shares of restricted stock units that vest on 7/1/17.
F3: 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
F4: Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.
F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.